Investor · 1 deal
Every published round State Path Capital took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Bionic Vision Technologies | Unnamed stage | 22 Nov 2018 | $23.6m | Participant | @AuManufacturing (Tue 12 Nov 2019), @AuManufacturing (Thu 22 Nov 2018) |
Companies State Path Capital has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Bionic Vision Technologies | 22 Nov 2018 | 1 | 0 |
Fund closes reported for State Path Capital, as distinct from the investments it has made.
Companies State Path Capital has backed that another company then bought. An exit for the holding, not a deal State Path Capital did.
Stories naming State Path Capital. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Comment piece reports bionic eye developers restored vision in four patients, with Bionic Vision Technologies having raised $23.6 million from two offshore investors, and discusses commercialisation prospects.
Also @AuManufacturing